Brain Neoplasms Flashcards
Brain tumors may originate from neural elements within the brain, or they may represent spread of distant cancers.
Gliomas, metastases, meningiomas, pituitary adenomas, acoustic neuromas account for …?
95% of all brain tumors.
Presenting complaints of pts with intracranial neoplasm tend to be …?
Similar for 1o brain tumors and intracranial metastases.
==> The onset of symptoms is usually insidious, but an acute episode may occur with bleeding into the tumor, or when an intraventricular tumor suddenly occludes the 3rd ventricle.
Manifestations may be nonspecific and include the following:
- Headache.
- Altered mental status.
- Ataxia.
- Nausea.
- Vomiting.
- Weakness.
- Gait disturbance.
CNS neoplasms may also manifest as follows:
- Focal seizures.
- Fixed visual changes.
- Speech deficits.
- Focal sensory abnormalities.
HEADACHE associated with intracranial neoplasms have the following characteristics:
- Often is a late complaint.
- Usually not an isolated finding.
- The worst symptom in only 1/2 of pts.
- Usually nonspecific an resembles tension-type headaches.
- In pts with established headache, may manifest as a change in the headache pattern.
- New onset of headaches in middle-aged or older pts is worrisome.
- The location of the headache reliably indicates the side of the head affected, but it does not indicate the precise site of the tumor.
- Headaches are more common with posterior fossa tumors.
- Headache is a more frequent symptom of intracranial tumor in pediatric pts.
Prevailing inaccurate portrayals of a tumor headache include the following:
- Pain that is worse in the early morning than at other times.
- Accompanying vomiting (+/- nausea).
- Exacerbation with Valsalva maneuvers, bending over, or rising from a recumbent position.
Physical findings of CNS neoplasms may include:
- Papilledema, which is more prevalent with pediatric brain tumor tumors, reflects an increase in ICP of several DAYS or longer.
- Diplopia may result from displacement or compression of the VI CN at the base of the brain.
- Impaired upward gaze, called Parinaud syndrome, may occur with pineal tumors.
- Tumors of the occipital lobe specifically may produce homonymous hemianopia or partial visual field deficits.
- Anosmia may occur with frontal lobe tumors.
- Brainstem and cerebellar tumors induce cranial nerve palsies, ataxia, incoordination, nystagmus, pyramidal signs, and sensory deficits on one or both sides of the body.
Diagnosis - With clinical suspicion of cancer, obtain …?
Routine lab studies on admission, including the following:
- CBC.
- Coagulation studies.
- Electrolyte levels.
- Comprehensive metabolic panel.
Obtain neuroimaging studies in pts with symptoms suggestive of an intracranial neoplasm, such as the following:
- Acute mental status changes.
- New-onset seizures.
- Focal motor or sensory deficits, including gait disturbances.
- Suspicious headache.
- Signs of elevated ICP (eg papilledema).
- Generally, CT is the imaging modality of choice for the ED physician.
CT findings are as follows:
- Most tumors demonstrate enhancement with contrast material administration.
- Tumors may appear hypodense, isodense, or hyperdense or have mixed density.
- Metastases to the brain tend to be multiple, but certain tumors (eg RCC) tend to produce SOLITARY metastatic brain lesions.
Features of MRI for imaging intracranial neoplasms:
- Most helpful for identifying tumors in the posterior fossa (including acoustic neuromas) and hemorrhagic lesions.
- Useful in pts with an allergy to iodinated contrast material or renal insufficiency.
- Drawbacks to MRI include incompatibility with certain medical equipment, longer imaging times (increased risk of motion artifact), and poor visualization of the subarachnoid space.
- Neither CT nor MRI can be used to differentiate tumor recurrence from RADIONECROSIS.
Management - Acute Tx for cerebral edema from intracranial neoplasms is as follows:
- CS may dramatically reduce signs and symptoms, bringing relief within a few hours.
- Dexamethasone is the agent of choice.
- Recommended doses generally range from 4-24mg daily.
Definitive Tx is as follows:
- Generally, care of pts with a brain tumor is multidisciplinary, requiring assistance from a neurosurgeon, an oncologist, a radiologist, and an expert in radiation therapy.
- Management varies greatly depending on tumor location, tissue type, and comorbid conditions.
- Surgical Tx options may include tumor removal or debulking, installation of a ventricular shunt, and placement of radioactive implants.
Background - Pathophysiology - Tumors of the brain produce neurologic manifestations through a number of mechanisms:
- Small, critically located tumors may damage specific neural pathways transversing the brain.
- Tumors can invade, infiltrate, or supplant normal parenchymal tissue, disrupting normal function.
- Because the brain dwells in the limited volume of the cranial vault, growth of intracranial tumors with accompanying edema may cause increased ICP.
- Tumors adjacent to the 3rd and 4th ventricles may impede the flow of CSF, leading to obstructive hydrocephalus.
- In addition, tumors generate new blood vessels (ie angiogenesis), disrupting the normal BBB and promoting edema.
The cumulative effects of tumor invasion, edema, and hydrocephalus may …?
Elevate the ICP and IMPAIR CEREBRAL PERFUSION.
==> Intracranial compartmental rise in ICP may provoke shifting or herniation of tissue under the falx cerebri, through the tentorium cerebelli, or through the foramen magnum.
Slow-growing tumors, particularly tumors expanding in the so-called silent areas of the brain, such as the frontal lobe, …?
May be associated with a more insidious clinical course.
==> These tumors tend to be larger at detection.
Most primary brain tumors do NOT metastasize, but if they do metastasize, …?
Intracranial spread precedes distant dissemination.
Leptomeningeal infiltration may present with …?
Dysfunction of multiple cranial nerves.
Frequency - US - The ACS estimates that …?
22,850 brain and other nervous system cancers will be diagnosed in 2015.
Estimates of the annual incidence rate of 1o brain tumors ranges from …?
7-19.1 /100.000.